LongeVC's Artemy Shumskiy to Speak at Advanced Therapies Europe 2026 in Barcelona
Artemy Shumskiy, principal at LongeVC, will join the Investment Summit at Phacilitate's Advanced Therapies Europe 2026 in Barcelona on September 7. He will speak on the panel "What it takes to fund advanced therapies in 2026" alongside investors from Advantary Capital Partners, Invivo Partners, Ysios Capital, and UCB Ventures.
The discussion will evolve around the shift from story-driven to evidence-driven investing: why scientific promise alone no longer closes rounds, and why data, manufacturing, regulatory strategy, and commercial pathways have become the non-negotiables of an investable company.